BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34262662)

  • 1. Desmoglein 3 contributes to tumorigenicity of pancreatic ductal adenocarcinoma through activating Src-FAK signaling.
    Abula Y; Su Y; Tuniyazi D; Yi C
    Anim Cells Syst (Seoul); 2021; 25(3):195-202. PubMed ID: 34262662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma.
    Ormanns S; Altendorf-Hofmann A; Jackstadt R; Horst D; Assmann G; Zhao Y; Bruns C; Kirchner T; Knösel T
    Br J Cancer; 2015 Nov; 113(10):1460-6. PubMed ID: 26469831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells.
    Zhang J; He DH; Zajac-Kaye M; Hochwald SN
    Cell Cycle; 2014; 13(19):3143-9. PubMed ID: 25486573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
    He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
    Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
    Begum A; Ewachiw T; Jung C; Huang A; Norberg KJ; Marchionni L; McMillan R; Penchev V; Rajeshkumar NV; Maitra A; Wood L; Wang C; Wolfgang C; DeJesus-Acosta A; Laheru D; Shapiro IM; Padval M; Pachter JA; Weaver DT; Rasheed ZA; Matsui W
    PLoS One; 2017; 12(7):e0180181. PubMed ID: 28692661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIOK3 promotes pancreatic ductal adenocarcinoma cell invasion and metastasis by stabilizing FAK.
    Xu M; Fang L; Guo X; Qin H; Sun R; Ning Z; Wang A
    Heliyon; 2022 Aug; 8(8):e10116. PubMed ID: 35982848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro.
    Mohamed AA; Thomsen A; Follo M; Zamboglou C; Bronsert P; Mostafa H; Amen A; Mekawy M; Grosu AL; Brunner TB
    Strahlenther Onkol; 2021 Jan; 197(1):27-38. PubMed ID: 32705304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
    Gu MM; Gao D; Yao PA; Yu L; Yang XD; Xing CG; Zhou J; Shang ZF; Li M
    Cancer Sci; 2018 Dec; 109(12):3783-3793. PubMed ID: 30281878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of desmoglein 2 and desmoglein 3 in esophageal squamous cell carcinoma.
    Fang WK; Gu W; Liao LD; Chen B; Wu ZY; Wu JY; Shen J; Xu LY; Li EM
    Asian Pac J Cancer Prev; 2014; 15(2):871-6. PubMed ID: 24568510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation.
    Brown L; Waseem A; Cruz IN; Szary J; Gunic E; Mannan T; Unadkat M; Yang M; Valderrama F; O'Toole EA; Wan H
    Oncogene; 2014 May; 33(18):2363-74. PubMed ID: 23752190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism.
    Muniyan S; Haridas D; Chugh S; Rachagani S; Lakshmanan I; Gupta S; Seshacharyulu P; Smith LM; Ponnusamy MP; Batra SK
    Genes Cancer; 2016 Mar; 7(3-4):110-124. PubMed ID: 27382435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.
    Kanteti R; Mirzapoiazova T; Riehm JJ; Dhanasingh I; Mambetsariev B; Wang J; Kulkarni P; Kaushik G; Seshacharyulu P; Ponnusamy MP; Kindler HL; Nasser MW; Batra SK; Salgia R
    Cancer Biol Ther; 2018 Apr; 19(4):316-327. PubMed ID: 29303405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.
    Tanouchi A; Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Kimura M; Watanabe R; Kohsaki T; Shimizu T; Saito M; Hanazaki K; Saibara T
    J Exp Clin Cancer Res; 2016 Dec; 35(1):190. PubMed ID: 27919290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells.
    Wuebben EL; Wilder PJ; Cox JL; Grunkemeyer JA; Caffrey T; Hollingsworth MA; Rizzino A
    Oncotarget; 2016 Jun; 7(23):34890-906. PubMed ID: 27145457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo.
    Aguirre Ghiso JA
    Oncogene; 2002 Apr; 21(16):2513-24. PubMed ID: 11971186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma.
    Le Large TYS; Bijlsma MF; El Hassouni B; Mantini G; Lagerweij T; Henneman AA; Funel N; Kok B; Pham TV; de Haas R; Morelli L; Knol JC; Piersma SR; Kazemier G; van Laarhoven HWM; Giovannetti E; Jimenez CR
    J Exp Clin Cancer Res; 2021 Mar; 40(1):91. PubMed ID: 33750427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELK Accelerates the Progression of Colorectal Cancer via Activating the FAK/Src Pathway.
    Liu G; Zhan W; Guo W; Hu F; Qin J; Li R; Liao X
    Biochem Genet; 2020 Oct; 58(5):771-782. PubMed ID: 32472210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Characterization of the Clinical Relevance of KPNA4 in Pancreatic Ductal Adenocarcinoma.
    Bao J; Xu C; Li B; Wu Z; Shen J; Song P; Peng Q; Hu G
    Front Oncol; 2022; 12():834728. PubMed ID: 35425701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
    Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
    J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.